StockNews.AI
CDLX
StockNews.AI
175 days

CDLX LAWSUIT ALERT: Levi & Korsinsky Notifies Cardlytics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

1. Class action lawsuit accuses CDLX of securities fraud. Alleged misstatements affected investor expectations. 2. Complaint cites misleading claims on consumer engagement and ad budget delivery. Investors impacted during early 2024. 3. Lawsuit alleges revenue growth risks tied to inaccurate positive statements. Investors may join without fees. 4. Levi & Korsinsky lead the litigation with a strong track record. Affected investors have until March 25, 2025.

4m saved
Insight
Article

FAQ

Why Bearish?

The lawsuit exposes potential vulnerabilities in CDLX operations, which may erode investor confidence. Historically, similar securities fraud allegations have led to notable short-term price declines as litigation unfolds.

How important is it?

The lawsuit may trigger regulatory scrutiny and investor uncertainty, potentially impacting CDLX's short-term share price. While the long-term effect may be limited if the case is resolved favorably, the litigation's visibility makes it a significant near-term event.

Why Short Term?

Legal risks typically impact stock prices in the short term as investors react to heightened uncertainty. Past cases show that litigation news can drive immediate volatility, even if long-term fundamentals remain unchanged.

Related Companies

CDLX
NEW YORK, Feb. 25, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Cardlytics investors who were adversely affected by alleged securities fraud between March 14, 2024 and August 7, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/cardlytics-lawsuit-submission-form?prid=131751&wire=4 CDLX investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) increasing consumer engagement led to an increase in consumer incentives; (2) the Company could not increase its billings commensurate with the increased consumer engagement; (3) as a result, there was a significant risk that its revenue growth would slow or decline; (4) the changes to Ads Decision Engine, which led to increased consumer engagement, led to the "under-delivery" of budgets and customers billing estimates; and (5) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. WHAT'S NEXT? If you suffered a loss in Cardlytics during the relevant time frame, you have until March 25, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate. WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. CONTACT:Levi & Korsinsky, LLP Joseph E. Levi, Esq.Ed Korsinsky, Esq.33 Whitehall Street, 17th FloorNew York, NY 10004[email protected] Tel: (212) 363-7500Fax: (212) 363-7171www.zlk.com SOURCE Levi & Korsinsky, LLP

Related News